Approach
How FosterWaller operates.
About
We are not a financial buyer.
FosterWaller was built by operators, not bankers. Our managing partners bring thirty years of pharmaceutical QA domain expertise and a technology infrastructure capability built for regulated environments. We acquire businesses we understand at an operational level — and we hold them permanently.
Operating Model
Acquire. Centralize. Deploy.
Acquire
We source and acquire QA operators with proven cash flows, recurring retainer or SaaS revenue, and established client relationships in FDA-regulated manufacturing. Deal structures are seller-friendly — earnouts, seller notes, equity participation where appropriate. No auction processes.
Centralize
Back-office consolidation across finance, HR, and administration. A shared quality management system deployed as the operating standard across all acquired entities. Shared regulatory intelligence monitoring FDA guidance, warning letters, and 483 observations. Cross-sell revenue flows naturally from shared clients who need services the platform now provides across multiple acquired firms.
Deploy
AI deployed across the entire platform simultaneously. Compliance document intelligence. Automated batch record workflows. Deviation pattern detection. CAPA routing and closure tracking. Predictive quality analytics on QC data. Regulatory monitoring. Applied at platform scale — the ROI is unavailable to any standalone operator.
For Sellers
We buy businesses that work. Then we make them compound.
Direct conversations.
We do not run auction processes. We identify operators we want to own, reach out directly, and have honest conversations about fit — on your timeline, not ours.
Seller-friendly structures.
Earnouts, seller notes, equity participation. We structure deals that work for founders who care about what happens after closing. Most of our sellers remain involved post-acquisition.
Permanent ownership.
We do not flip. The business you built continues under the FosterWaller platform. The team continues. The client relationships continue. We add infrastructure, technology, and capital.
Technology
AI deployed at platform scale.
The technology layer that makes a QA platform worth multiples of its parts is now buildable. FosterWaller deploys AI across the entire portfolio simultaneously after each acquisition.
Compliance Document Intelligence
Automated SOP review, deviation classification, audit finding pattern detection.
Batch Record Automation
Auto-population, review workflow routing, exception flagging.
CAPA Workflow Automation
Deviation-to-CAPA routing, effectiveness check scheduling, closure tracking.
Regulatory Monitoring
Automated FDA guidance updates, warning letter analysis, 483 trend tracking.
Predictive Quality Analytics
QC data trend analysis to surface failure signals before they become deviations.
Supplier Qualification
Automated supplier risk scoring and audit scheduling optimization.
Start a Conversation
We partner where QA infrastructure matters.
If you're operating in pharmaceutical or supplement manufacturing QA and considering a transition — we'd like to understand what you've built.